Deciphera Pharmaceuticals, Inc. Restructuring Charges
Deciphera Pharmaceuticals, Inc. reported Restructuring Charges of $26.20 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. restructuring charges for the quarter ending 2022-06-30 was $26.20M.
- Deciphera Pharmaceuticals, Inc. restructuring charges for the quarter ending 2022-03-31 was $26.20M.
- Deciphera Pharmaceuticals, Inc. restructuring charges for the quarter ending 2021-12-31 was $26.17M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month |
|---|---|---|---|
| 2022-06-30 | $26.20M 10-Q · filed 2022-11-03 | $52.40M derived: sum of 2 quarters · filed 2022-11-03 | $78.57M derived: sum of 3 quarters · filed 2024-02-07 |
| 2022-03-31 | $26.20M 10-Q · filed 2022-08-04 | $52.37M derived: sum of 2 quarters · filed 2024-02-07 | |
| 2021-12-31 | $26.17M 10-K · filed 2024-02-07 |